90.93
price up icon3.33%   2.93
after-market Handel nachbörslich: 90.93
loading
Schlusskurs vom Vortag:
$88.00
Offen:
$88.55
24-Stunden-Volumen:
1.61M
Relative Volume:
1.26
Marktkapitalisierung:
$10.55B
Einnahmen:
$2.77B
Nettoeinkommen (Verlust:
$286.61M
KGV:
38.69
EPS:
2.35
Netto-Cashflow:
$524.11M
1W Leistung:
+5.86%
1M Leistung:
-10.41%
6M Leistung:
-19.45%
1J Leistung:
-23.63%
1-Tages-Spanne:
Value
$87.94
$91.17
1-Wochen-Bereich:
Value
$85.51
$91.17
52-Wochen-Spanne:
Value
$85.12
$129.50

Revvity Inc Stock (RVTY) Company Profile

Name
Firmenname
Revvity Inc
Name
Telefon
781-663-6900
Name
Adresse
77 4TH AVENUE, WALTHAM
Name
Mitarbeiter
11,000
Name
Twitter
Name
Nächster Verdiensttermin
2025-07-28
Name
Neueste SEC-Einreichungen
Name
RVTY's Discussions on Twitter

Vergleichen Sie RVTY mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
RVTY
Revvity Inc
90.93 10.21B 2.77B 286.61M 524.11M 2.35
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
484.79 180.28B 43.21B 6.58B 6.17B 17.29
Diagnostics & Research icon
DHR
Danaher Corp
209.14 147.31B 24.01B 3.41B 4.86B 4.70
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
663.92 52.18B 4.04B 985.66M 774.34M 12.01
Diagnostics & Research icon
A
Agilent Technologies Inc
120.29 33.33B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
190.23 31.60B 15.50B 1.33B 2.16B 7.34

Revvity Inc Stock (RVTY) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-01 Hochstufung UBS Neutral → Buy
2025-01-10 Herabstufung Bernstein Outperform → Mkt Perform
2024-12-13 Hochstufung BofA Securities Neutral → Buy
2024-10-15 Hochstufung Barclays Equal Weight → Overweight
2024-08-28 Eingeleitet Wells Fargo Equal Weight
2024-07-08 Eingeleitet Leerink Partners Outperform
2024-06-03 Fortgesetzt Jefferies Hold
2024-01-16 Herabstufung UBS Buy → Neutral
2024-01-04 Hochstufung Evercore ISI In-line → Outperform
2023-12-19 Eingeleitet Wells Fargo Equal Weight
2023-12-13 Eingeleitet Wolfe Research Peer Perform
2023-09-28 Eingeleitet Bernstein Outperform
2023-07-19 Eingeleitet Raymond James Outperform
2023-05-23 Fortgesetzt Goldman Buy
Alle ansehen

Revvity Inc Aktie (RVTY) Neueste Nachrichten

pulisher
05:51 AM

NeoGenomics, Progyny, Repligen, Revvity, and Waters Corporation Shares Are Soaring, What You Need To Know - uk.finance.yahoo.com

05:51 AM
pulisher
04:45 AM

The Top 5 Analyst Questions From Revvity’s Q2 Earnings Call - Yahoo Finance

04:45 AM
pulisher
03:58 AM

Is Revvity's pHSense Launch Shaping Its Innovation Strategy and Consumables Revenue Mix (RVTY)? - simplywall.st

03:58 AM
pulisher
Aug 12, 2025

Stock Analysis | Revvity OutlookWeak Technicals and Pessimistic Analysts Call for Caution - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Stock Market Rally: Revvity, Avantor, Azenta, Bio-Techne, Amneal Shares Surge Amid Fed Interest Rate Cut Hopes - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Revvity, Avantor, Azenta, Bio-Techne, and Amneal Shares Skyrocket, What You Need To Know - Yahoo Finance

Aug 12, 2025
pulisher
Aug 11, 2025

Revvity Inc. stock underperforms Monday when compared to competitors - MarketWatch

Aug 11, 2025
pulisher
Aug 09, 2025

What makes Revvity Inc. stock price move sharplyFast Return with Technical Confirmation - thegnnews.com

Aug 09, 2025
pulisher
Aug 08, 2025

Revvity’s pHSense Enables High Throughput Internalization - Precedence Research

Aug 08, 2025
pulisher
Aug 07, 2025

Revvity targets 2%-4% organic growth for 2025 as China diagnostics faces new policy headwinds - MSN

Aug 07, 2025
pulisher
Aug 07, 2025

Revvity's (NYSE:RVTY) Performance Is Even Better Than Its Earnings Suggest - Yahoo Finance

Aug 07, 2025
pulisher
Aug 06, 2025

Revvity Launches Innovative Reagent Technology to Accelerate Development of Next-Generation Targeted Therapeutics - Lelezard

Aug 06, 2025
pulisher
Aug 06, 2025

Revvity Unveils PHSense Reagents To Advance Internalization Studies In Drug Discovery - 富途牛牛

Aug 06, 2025
pulisher
Aug 06, 2025

Revvity launches innovative reagent technology to accelerate therapeutics development - BioSpectrum Asia

Aug 06, 2025
pulisher
Aug 06, 2025

Revvity Launches Innovative Reagent Technology to Accelerate Dev - GuruFocus

Aug 06, 2025
pulisher
Aug 06, 2025

Revvity 2025 Q2 Earnings Sustained Profitability Amid Slight Earnings Decline - AInvest

Aug 06, 2025
pulisher
Aug 06, 2025

3 Healthcare Stocks to Avoid: GE HealthCare, Universal Health Services, and Revvity - AInvest

Aug 06, 2025
pulisher
Aug 04, 2025

Earnings Preview: What to Expect From Revvity's Report - MSN

Aug 04, 2025
pulisher
Aug 04, 2025

What's Going On With Revvity Stock Today? - 富途牛牛

Aug 04, 2025
pulisher
Aug 04, 2025

Revvity Inc.’s Price Action Aligns with Quant SignalsBreakout Confirmation With Entry Tracker Enabled - metal.it

Aug 04, 2025
pulisher
Aug 04, 2025

Shareholders Will Be Pleased With The Quality of Revvity's (NYSE:RVTY) Earnings - 富途牛牛

Aug 04, 2025
pulisher
Aug 03, 2025

Is it the right time to buy Revvity Inc. stockTurn volatility into profit opportunities - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are Revvity Inc. company’s key revenue driversOutstanding capital appreciation - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are the technical indicators suggesting about Revvity Inc.Consistent high-performance stocks - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does Revvity Inc. generate profit in a changing economyConsistently superior profits - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is the dividend policy of Revvity Inc. stockCapitalize on market momentum for maximum profit - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Revvity, Inc. Stock (RVTY) Opinions on Quarterly Earnings Report - Quiver Quantitative

Aug 03, 2025
pulisher
Aug 03, 2025

What is the risk reward ratio of investing in Revvity Inc. stockUnlock steady growth with low-risk stocks - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is Revvity Inc. a good long term investmentExceptional trading results - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Does Revvity Inc. stock perform well during market downturnsInvest confidently with real-time updates - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How many analysts rate Revvity Inc. as a “Buy”Achieve consistent double-digit growth - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Why is Revvity Inc. stock attracting strong analyst attentionFree Capital Efficiency Planning - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

When is Revvity Inc. stock expected to show significant growthGain the edge with real-time market data - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

What institutional investors are buying Revvity Inc. stockHigh-yield trading alerts - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

How strong is Revvity Inc. company’s balance sheetFree Technical Analysis Support - Jammu Links News

Aug 02, 2025
pulisher
Aug 01, 2025

Is Revvity Inc. a growth stock or a value stockBest Dividend Forecasts To Watch Now - Jammu Links News

Aug 01, 2025
pulisher
Aug 01, 2025

Revvity stock hits 52-week low at 87.63 USD - Investing.com Australia

Aug 01, 2025
pulisher
Aug 01, 2025

Revvity stock hits 52-week low at 87.63 USD By Investing.com - Investing.com Canada

Aug 01, 2025
pulisher
Jul 30, 2025

Tesla, AMD, SMCI, Nike, Revvity: Stocks Making The Biggest Moves Today - Stocktwits

Jul 30, 2025
pulisher
Jul 30, 2025

Revvity price target lowered to $110 from $120 at Stifel - Yahoo Finance

Jul 30, 2025
pulisher
Jul 30, 2025

A Quick Look at Today's Ratings for Revvity(RVTY.US), With a Forecast Between $102 to $115 - 富途牛牛

Jul 30, 2025
pulisher
Jul 30, 2025

Revvity Repeat Insider Selling Not A Positive Indicator - 富途牛牛

Jul 30, 2025
pulisher
Jul 29, 2025

Revvity, Inc. Earnings Call: Mixed Sentiment and Strategic Moves - The Globe and Mail

Jul 29, 2025
pulisher
Jul 29, 2025

Revvity Inc. Earnings Report Breakdown: What Investors Should KnowMulti-Bagger Potential Stock Forecast Tools Released - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Stifel lowers Revvity stock price target to $110 on China ImmunoDx pressures - Investing.com Nigeria

Jul 29, 2025
pulisher
Jul 29, 2025

Stifel lowers Revvity stock price target to $110 on China ImmunoDx pressures By Investing.com - Investing.com South Africa

Jul 29, 2025
pulisher
Jul 29, 2025

Raymond James lowers Revvity stock price target to $115 on China headwinds - Investing.com Nigeria

Jul 29, 2025

Finanzdaten der Revvity Inc-Aktie (RVTY)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
diagnostics_research WAT
$296.83
price up icon 3.96%
diagnostics_research DGX
$179.04
price up icon 0.20%
$157.70
price down icon 1.32%
diagnostics_research LH
$272.54
price up icon 1.20%
diagnostics_research MTD
$1,324.06
price up icon 2.41%
diagnostics_research IQV
$190.23
price up icon 2.32%
Kapitalisierung:     |  Volumen (24h):